Suntrust Banks’s Vertex Pharmaceuticals VRTX Stock Holding History

Suntrust Banks’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$3.01M	Buy	17,785 +1,939	+12%	+$343K	0.02%	474
2019 Q2	$2.91M	Buy	15,846 +1,372	+9%	+$240K	0.02%	483
2019 Q1	$2.66M	Buy	14,474 +854	+6%	+$158K	0.01%	484
2018 Q4	$2.26M	Buy	13,620 +1,062	+8%	+$184K	0.01%	489
2018 Q3	$2.42M	Buy	12,558 +3,297	+36%	+$587K	0.01%	503
2018 Q2	$1.57M	Buy	9,261 +555	+6%	+$86K	0.01%	617
2018 Q1	$1.42M	Buy	8,706 +2,603	+43%	+$425K	0.01%	629
2017 Q4	$914K	Sell	6,103 -18,310	-75%	-$2.71M	0.01%	718
2017 Q3	$3.71M	Buy	24,413 +1,918	+9%	+$289K	0.02%	361
2017 Q2	$2.9M	Buy	22,495 +3,126	+16%	+$376K	0.02%	392
2017 Q1	$2.12M	Sell	19,369 -1,220	-6%	-$107K	0.01%	458
2016 Q4	$1.51M	Sell	20,589 -768	-4%	-$62.5K	0.01%	664
2016 Q3	$1.86M	Buy	21,357 +966	+5%	+$91.3K	0.01%	573
2016 Q2	$1.75M	Sell	20,391 -1,026	-5%	-$88.7K	0.01%	547
2016 Q1	$1.7M	Buy	21,417 +5,961	+39%	+$539K	0.01%	522
2015 Q4	$1.94M	Buy	+15,456	New	+$1.87M	0.01%	470
2014 Q2	–	Sell	-3,801	Closed	-$267K	–	1693
2014 Q1	$267K	Sell	3,801 -182	-5%	-$14.4K	﹤0.01%	1640
2013 Q4	$294K	Sell	3,983 -1,110	-22%	-$77.3K	﹤0.01%	1531
2013 Q3	$384K	Sell	5,093 -25,673	-83%	-$2.04M	﹤0.01%	1364
2013 Q2	$2.46M	Buy	+30,766	New	+$2.27M	0.01%	574

Other funds holding VRTX

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Suntrust Banks's VRTX Position: Q3 2019 in Review

Suntrust Banks increased its Vertex Pharmaceuticals (VRTX) stake by 12% in Q3 2019, buying an estimated $343K and bringing the position to 17,785 shares worth $3.01M. The position accounts for 0.02% of the portfolio, ranked #474.

Suntrust Banks first reported a position in VRTX in Q2 2013 and has held it in 20 quarters since. The position peaked at $3.71M in Q3 2017. 708 funds tracked by Wall St. Rank hold VRTX as of Q3 2019.

Suntrust Banks held 17,785 shares of Vertex Pharmaceuticals worth $3.01M as of Q3 2019.
Suntrust Banks bought 1,939 Vertex Pharmaceuticals shares in Q3 2019, an estimated $343K.
Vertex Pharmaceuticals made up 0.02% of Suntrust Banks's portfolio in Q3 2019, its #474 holding.
Suntrust Banks first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 20 quarters since.
Suntrust Banks's Vertex Pharmaceuticals position peaked at $3.71M in Q3 2017.
708 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.